FTC sues drug middlemen for allegedly inflating insulin prices
Source: CNBC
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.